JP2004537983A - ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 - Google Patents

Info

Publication number

JP2004537983A

JP2004537983A JP2002583469A JP2002583469A JP2004537983A JP 2004537983 A JP2004537983 A JP 2004537983A JP 2002583469 A JP2002583469 A JP 2002583469A JP 2002583469 A JP2002583469 A JP 2002583469A JP 2004537983 A JP2004537983 A JP 2004537983A

Authority

JP

Japan

Prior art keywords

nucleic acid

abcc12

polypeptide

nucleotide

seq

Prior art date

2001-03-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 357
• 102000039446 nucleic acids Human genes 0.000 title claims abstract description 340
• 108020004707 nucleic acids Proteins 0.000 title claims abstract description 340
• 239000013598 vector Substances 0.000 title claims abstract description 177
• 101100238527 Homo sapiens ABCC12 gene Proteins 0.000 title description 16
• 101001029062 Homo sapiens ATP-binding cassette sub-family C member 12 Proteins 0.000 claims abstract description 291
• 102100037131 ATP-binding cassette sub-family C member 12 Human genes 0.000 claims abstract description 267
• 125000003729 nucleotide group Chemical group 0.000 claims abstract description 267
• 239000002773 nucleotide Substances 0.000 claims abstract description 265
• 239000000523 sample Substances 0.000 claims abstract description 84
• 101150067199 abcC12 gene Proteins 0.000 claims abstract description 43
• 108020004635 Complementary DNA Proteins 0.000 claims abstract description 39
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 292
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 283
• 229920001184 polypeptide Polymers 0.000 claims description 279
• 238000000034 method Methods 0.000 claims description 139
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 96
• 239000012634 fragment Substances 0.000 claims description 73
• 239000003814 drug Substances 0.000 claims description 72
• 230000000295 complement effect Effects 0.000 claims description 68
• 241000701161 unidentified adenovirus Species 0.000 claims description 46
• 238000009396 hybridization Methods 0.000 claims description 38
• 206010008754 Choreoathetosis Diseases 0.000 claims description 37
• 239000008194 pharmaceutical composition Substances 0.000 claims description 37
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 37
• 150000001875 compounds Chemical class 0.000 claims description 36
• 230000001314 paroxysmal effect Effects 0.000 claims description 36
• 238000011282 treatment Methods 0.000 claims description 36
• 238000004519 manufacturing process Methods 0.000 claims description 30
• 239000003550 marker Substances 0.000 claims description 30
• 238000012216 screening Methods 0.000 claims description 28
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 26
• 150000001450 anions Chemical class 0.000 claims description 23
• 230000002265 prevention Effects 0.000 claims description 23
• 238000006243 chemical reaction Methods 0.000 claims description 22
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 22
• 239000000556 agonist Substances 0.000 claims description 21
• 239000005557 antagonist Substances 0.000 claims description 21
• 230000003321 amplification Effects 0.000 claims description 19
• 239000000758 substrate Substances 0.000 claims description 18
• 238000001514 detection method Methods 0.000 claims description 16
• 239000012528 membrane Substances 0.000 claims description 16
• 239000003153 chemical reaction reagent Substances 0.000 claims description 15
• 239000007943 implant Substances 0.000 claims description 9
• 239000000427 antigen Substances 0.000 claims description 8
• 108091007433 antigens Proteins 0.000 claims description 8
• 102000036639 antigens Human genes 0.000 claims description 8
• 239000004480 active ingredient Substances 0.000 claims description 4
• 238000011321 prophylaxis Methods 0.000 claims description 4
• 238000005406 washing Methods 0.000 claims description 3
• 238000009007 Diagnostic Kit Methods 0.000 claims 1
• 108010029485 Protein Isoforms Proteins 0.000 abstract description 109
• 102000001708 Protein Isoforms Human genes 0.000 abstract description 109
• 230000035772 mutation Effects 0.000 abstract description 17
• 102000054765 polymorphisms of proteins Human genes 0.000 abstract description 4
• 108700028369 Alleles Proteins 0.000 abstract description 3
• 210000004027 cell Anatomy 0.000 description 243
• 108090000623 proteins and genes Proteins 0.000 description 179
• 108020004414 DNA Proteins 0.000 description 104
• 230000014509 gene expression Effects 0.000 description 77
• 102000004169 proteins and genes Human genes 0.000 description 71
• 235000018102 proteins Nutrition 0.000 description 68
• 241000700605 Viruses Species 0.000 description 65
• 239000013615 primer Substances 0.000 description 62
• 239000002299 complementary DNA Substances 0.000 description 60
• 229940079593 drug Drugs 0.000 description 55
• 235000001014 amino acid Nutrition 0.000 description 50
• 239000000203 mixture Substances 0.000 description 49
• 230000001105 regulatory effect Effects 0.000 description 49
• 150000001413 amino acids Chemical class 0.000 description 48
• 238000001727 in vivo Methods 0.000 description 47
• 229940024606 amino acid Drugs 0.000 description 46
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 40
• 241000282414 Homo sapiens Species 0.000 description 38
• 230000032258 transport Effects 0.000 description 37
• 108091026890 Coding region Proteins 0.000 description 36
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 35
• 241001465754 Metazoa Species 0.000 description 35
• 230000002950 deficient Effects 0.000 description 35
• 229960000485 methotrexate Drugs 0.000 description 35
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
• 238000010367 cloning Methods 0.000 description 31
• 239000013604 expression vector Substances 0.000 description 31
• 102000040430 polynucleotide Human genes 0.000 description 31
• 108091033319 polynucleotide Proteins 0.000 description 31
• 239000002157 polynucleotide Substances 0.000 description 31
• 239000000047 product Substances 0.000 description 30
• 230000007170 pathology Effects 0.000 description 29
• 108020004999 messenger RNA Proteins 0.000 description 25
• 201000010099 disease Diseases 0.000 description 24
• 239000013612 plasmid Substances 0.000 description 24
• 210000001519 tissue Anatomy 0.000 description 24
• 239000003981 vehicle Substances 0.000 description 23
• 230000000694 effects Effects 0.000 description 22
• 230000027455 binding Effects 0.000 description 21
• 239000003446 ligand Substances 0.000 description 21
• 230000002378 acidificating effect Effects 0.000 description 20
• 229960003180 glutathione Drugs 0.000 description 20
• 239000000126 substance Substances 0.000 description 20
• 241001430294 unidentified retrovirus Species 0.000 description 20
• 230000006870 function Effects 0.000 description 19
• 239000002987 primer (paints) Substances 0.000 description 19
• 238000013518 transcription Methods 0.000 description 19
• 230000035897 transcription Effects 0.000 description 19
• AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 18
• 108091034117 Oligonucleotide Proteins 0.000 description 18
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 18
• 230000002759 chromosomal effect Effects 0.000 description 18
• 229940097042 glucuronate Drugs 0.000 description 18
• 230000007935 neutral effect Effects 0.000 description 18
• 125000000129 anionic group Chemical group 0.000 description 17
• 238000000338 in vitro Methods 0.000 description 17
• 230000004048 modification Effects 0.000 description 17
• 238000012986 modification Methods 0.000 description 17
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
• 102000050218 human ABCC12 Human genes 0.000 description 16
• 239000000243 solution Substances 0.000 description 16
• 238000006467 substitution reaction Methods 0.000 description 16
• 230000014616 translation Effects 0.000 description 16
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
• 238000007792 addition Methods 0.000 description 15
• 210000000349 chromosome Anatomy 0.000 description 15
• 238000013519 translation Methods 0.000 description 15
• 238000005516 engineering process Methods 0.000 description 14
• 210000004408 hybridoma Anatomy 0.000 description 14
• 238000013459 approach Methods 0.000 description 13
• 230000007812 deficiency Effects 0.000 description 13
• 238000012217 deletion Methods 0.000 description 13
• 230000037430 deletion Effects 0.000 description 13
• 208000015181 infectious disease Diseases 0.000 description 13
• 150000002632 lipids Chemical class 0.000 description 13
• 230000001225 therapeutic effect Effects 0.000 description 13
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 12
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 11
• 239000002751 oligonucleotide probe Substances 0.000 description 11
• 238000001890 transfection Methods 0.000 description 11
• 108010078791 Carrier Proteins Proteins 0.000 description 10
• 241000701022 Cytomegalovirus Species 0.000 description 10
• 239000002502 liposome Substances 0.000 description 10
• 210000004962 mammalian cell Anatomy 0.000 description 10
• 238000012546 transfer Methods 0.000 description 10
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
• 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 9
• 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 9
• 102000053602 DNA Human genes 0.000 description 9
• 239000003155 DNA primer Substances 0.000 description 9
• 101000986629 Homo sapiens ATP-binding cassette sub-family C member 4 Proteins 0.000 description 9
• 101000986622 Homo sapiens ATP-binding cassette sub-family C member 5 Proteins 0.000 description 9
• 125000000539 amino acid group Chemical group 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 210000004185 liver Anatomy 0.000 description 9
• 108091008146 restriction endonucleases Proteins 0.000 description 9
• 102100028163 ATP-binding cassette sub-family C member 4 Human genes 0.000 description 8
• 101001029057 Homo sapiens ATP-binding cassette sub-family C member 11 Proteins 0.000 description 8
• 102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 description 8
• 108010076504 Protein Sorting Signals Proteins 0.000 description 8
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
• 235000012000 cholesterol Nutrition 0.000 description 8
• 239000013599 cloning vector Substances 0.000 description 8
• 230000006798 recombination Effects 0.000 description 8
• 239000013605 shuttle vector Substances 0.000 description 8
• 150000003384 small molecules Chemical class 0.000 description 8
• 102100037129 ATP-binding cassette sub-family C member 11 Human genes 0.000 description 7
• 108020004705 Codon Proteins 0.000 description 7
• 108700024394 Exon Proteins 0.000 description 7
• 108091060211 Expressed sequence tag Proteins 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 238000002744 homologous recombination Methods 0.000 description 7
• 230000006801 homologous recombination Effects 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 238000010369 molecular cloning Methods 0.000 description 7
• 238000005215 recombination Methods 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 238000002560 therapeutic procedure Methods 0.000 description 7
• 238000002054 transplantation Methods 0.000 description 7
• 230000003612 virological effect Effects 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
• 241000282472 Canis lupus familiaris Species 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 101000969812 Homo sapiens Multidrug resistance-associated protein 1 Proteins 0.000 description 6
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 6
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 6
• 241000124008 Mammalia Species 0.000 description 6
• 241000699670 Mus sp. Species 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 230000001580 bacterial effect Effects 0.000 description 6
• 230000000975 bioactive effect Effects 0.000 description 6
• 230000004071 biological effect Effects 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 238000009472 formulation Methods 0.000 description 6
• 230000002757 inflammatory effect Effects 0.000 description 6
• 238000005259 measurement Methods 0.000 description 6
• 238000000691 measurement method Methods 0.000 description 6
• 230000004899 motility Effects 0.000 description 6
• 230000000069 prophylactic effect Effects 0.000 description 6
• 238000000746 purification Methods 0.000 description 6
• 230000001177 retroviral effect Effects 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 5
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 5
• 102100028186 ATP-binding cassette sub-family C member 5 Human genes 0.000 description 5
• 241000894006 Bacteria Species 0.000 description 5
• 241000238631 Hexapoda Species 0.000 description 5
• 241001529936 Murinae Species 0.000 description 5
• 206010028980 Neoplasm Diseases 0.000 description 5
• 241001494479 Pecora Species 0.000 description 5
• 108020004511 Recombinant DNA Proteins 0.000 description 5
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
• 108091081024 Start codon Proteins 0.000 description 5
• 108010022394 Threonine synthase Proteins 0.000 description 5
• WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 5
• 239000002671 adjuvant Substances 0.000 description 5
• 210000000234 capsid Anatomy 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 210000004748 cultured cell Anatomy 0.000 description 5
• 230000007547 defect Effects 0.000 description 5
• 102000004419 dihydrofolate reductase Human genes 0.000 description 5
• 230000004064 dysfunction Effects 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 210000003527 eukaryotic cell Anatomy 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 239000001963 growth medium Substances 0.000 description 5
• 230000001771 impaired effect Effects 0.000 description 5
• 230000036457 multidrug resistance Effects 0.000 description 5
• 238000007899 nucleic acid hybridization Methods 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• -1 phosphate ester Chemical class 0.000 description 5
• 230000008488 polyadenylation Effects 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 241000701447 unidentified baculovirus Species 0.000 description 5
• 239000013603 viral vector Substances 0.000 description 5
• 244000105975 Antidesma platyphyllum Species 0.000 description 4
• 241000283690 Bos taurus Species 0.000 description 4
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• 241000702421 Dependoparvovirus Species 0.000 description 4
• 229920002307 Dextran Polymers 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
• 101000986621 Homo sapiens ATP-binding cassette sub-family C member 6 Proteins 0.000 description 4
• 101000760570 Homo sapiens ATP-binding cassette sub-family C member 8 Proteins 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 238000012408 PCR amplification Methods 0.000 description 4
• 241000700584 Simplexvirus Species 0.000 description 4
• 241000700618 Vaccinia virus Species 0.000 description 4
• 230000002159 abnormal effect Effects 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 230000000890 antigenic effect Effects 0.000 description 4
• 238000003556 assay Methods 0.000 description 4
• 108010005774 beta-Galactosidase Proteins 0.000 description 4
• 210000004556 brain Anatomy 0.000 description 4
• 201000011510 cancer Diseases 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 238000004520 electroporation Methods 0.000 description 4
• 238000002474 experimental method Methods 0.000 description 4
• 210000002744 extracellular matrix Anatomy 0.000 description 4
• 210000002950 fibroblast Anatomy 0.000 description 4
• 230000005714 functional activity Effects 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 235000009424 haa Nutrition 0.000 description 4
• 210000005260 human cell Anatomy 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 230000007774 longterm Effects 0.000 description 4
• 238000013507 mapping Methods 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 210000003240 portal vein Anatomy 0.000 description 4
• 238000001556 precipitation Methods 0.000 description 4
• 238000012545 processing Methods 0.000 description 4
• 238000003259 recombinant expression Methods 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 238000003757 reverse transcription PCR Methods 0.000 description 4
• 210000001550 testis Anatomy 0.000 description 4
• 230000009466 transformation Effects 0.000 description 4
• 230000009261 transgenic effect Effects 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
• 102100028161 ATP-binding cassette sub-family C member 2 Human genes 0.000 description 3
• 102100028162 ATP-binding cassette sub-family C member 3 Human genes 0.000 description 3
• 102100024645 ATP-binding cassette sub-family C member 8 Human genes 0.000 description 3
• 108010085238 Actins Proteins 0.000 description 3
• 102000007469 Actins Human genes 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 102000008186 Collagen Human genes 0.000 description 3
• 108010035532 Collagen Proteins 0.000 description 3
• 206010010904 Convulsion Diseases 0.000 description 3
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
• 241000282326 Felis catus Species 0.000 description 3
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 3
• 101000986633 Homo sapiens ATP-binding cassette sub-family C member 3 Proteins 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• 108090000862 Ion Channels Proteins 0.000 description 3
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• 102000018697 Membrane Proteins Human genes 0.000 description 3
• 108010066419 Multidrug Resistance-Associated Protein 2 Proteins 0.000 description 3
• 238000000636 Northern blotting Methods 0.000 description 3
• 102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 102000006601 Thymidine Kinase Human genes 0.000 description 3
• 108020004440 Thymidine kinase Proteins 0.000 description 3
• 108700005077 Viral Genes Proteins 0.000 description 3
• 208000026935 allergic disease Diseases 0.000 description 3
• 210000004436 artificial bacterial chromosome Anatomy 0.000 description 3
• 239000013602 bacteriophage vector Substances 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 229910000389 calcium phosphate Inorganic materials 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 125000002091 cationic group Chemical group 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 210000002230 centromere Anatomy 0.000 description 3
• 229920001436 collagen Polymers 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 238000004925 denaturation Methods 0.000 description 3
• 230000036425 denaturation Effects 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 108700004026 gag Genes Proteins 0.000 description 3
• 239000003349 gelling agent Substances 0.000 description 3
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
• 210000003917 human chromosome Anatomy 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 230000002163 immunogen Effects 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 238000001155 isoelectric focusing Methods 0.000 description 3
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 3
• 125000005647 linker group Chemical group 0.000 description 3
• 230000002934 lysing effect Effects 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 238000000520 microinjection Methods 0.000 description 3
• 210000003205 muscle Anatomy 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 208000013667 paroxysmal dyskinesia Diseases 0.000 description 3
• 230000008506 pathogenesis Effects 0.000 description 3
• 238000013081 phylogenetic analysis Methods 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 230000000644 propagated effect Effects 0.000 description 3
• 230000005855 radiation Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 238000002741 site-directed mutagenesis Methods 0.000 description 3
• 210000002460 smooth muscle Anatomy 0.000 description 3
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 3
• 238000000527 sonication Methods 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 210000003014 totipotent stem cell Anatomy 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• JTEGQNOMFQHVDC-RQJHMYQMSA-N 4-amino-1-[(2s,5r)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)SC1 JTEGQNOMFQHVDC-RQJHMYQMSA-N 0.000 description 2
• 102100037128 ATP-binding cassette sub-family C member 10 Human genes 0.000 description 2
• 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 2
• 206010067484 Adverse reaction Diseases 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 101150044789 Cap gene Proteins 0.000 description 2
• 206010008748 Chorea Diseases 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 201000003883 Cystic fibrosis Diseases 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010013369 Enteropeptidase Proteins 0.000 description 2
• 102100029727 Enteropeptidase Human genes 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 2
• 208000036566 Erythroleukaemia Diseases 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 101001029059 Homo sapiens ATP-binding cassette sub-family C member 10 Proteins 0.000 description 2
• 101000760581 Homo sapiens ATP-binding cassette sub-family C member 9 Proteins 0.000 description 2
• 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 2
• 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 2
• 101000801643 Homo sapiens Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 description 2
• 241000598171 Human adenovirus sp. Species 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 108090000157 Metallothionein Proteins 0.000 description 2
• 108091061960 Naked DNA Proteins 0.000 description 2
• 108091092724 Noncoding DNA Proteins 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 102000007990 Organic Anion Transporters Human genes 0.000 description 2
• 108010089503 Organic Anion Transporters Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 206010065657 Paroxysmal choreoathetosis Diseases 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• 102000057297 Pepsin A Human genes 0.000 description 2
• 108090000284 Pepsin A Proteins 0.000 description 2
• 102000007079 Peptide Fragments Human genes 0.000 description 2
• 108010033276 Peptide Fragments Proteins 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 241000276498 Pollachius virens Species 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 102100033617 Retinal-specific phospholipid-transporting ATPase ABCA4 Human genes 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 241000282887 Suidae Species 0.000 description 2
• 108010091821 Sulfonylurea Receptors Proteins 0.000 description 2
• 102000018692 Sulfonylurea Receptors Human genes 0.000 description 2
• 208000001163 Tangier disease Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 108700009124 Transcription Initiation Site Proteins 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• 208000021841 acute erythroid leukemia Diseases 0.000 description 2
• 230000006838 adverse reaction Effects 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 239000007900 aqueous suspension Substances 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 102000005936 beta-Galactosidase Human genes 0.000 description 2
• 239000012620 biological material Substances 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 230000007910 cell fusion Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000001311 chemical methods and process Methods 0.000 description 2
• 235000013330 chicken meat Nutrition 0.000 description 2
• 239000013611 chromosomal DNA Substances 0.000 description 2
• 238000012761 co-transfection Methods 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 239000003636 conditioned culture medium Substances 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 238000009109 curative therapy Methods 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 208000002173 dizziness Diseases 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 210000002889 endothelial cell Anatomy 0.000 description 2
• 108700004025 env Genes Proteins 0.000 description 2
• 239000012894 fetal calf serum Substances 0.000 description 2
• 239000000945 filler Substances 0.000 description 2
• 230000002496 gastric effect Effects 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 208000016361 genetic disease Diseases 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 229910052737 gold Inorganic materials 0.000 description 2
• 210000003494 hepatocyte Anatomy 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000010253 intravenous injection Methods 0.000 description 2
• 239000000644 isotonic solution Substances 0.000 description 2
• 230000000155 isotopic effect Effects 0.000 description 2
• 238000005304 joining Methods 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 238000001638 lipofection Methods 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• SXTAYKAGBXMACB-UHFFFAOYSA-N methionine sulfoximine Chemical compound CS(=N)(=O)CCC(N)C(O)=O SXTAYKAGBXMACB-UHFFFAOYSA-N 0.000 description 2
• 235000010446 mineral oil Nutrition 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 108010066052 multidrug resistance-associated protein 1 Proteins 0.000 description 2
• 201000000050 myeloid neoplasm Diseases 0.000 description 2
• 210000003098 myoblast Anatomy 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 238000002515 oligonucleotide synthesis Methods 0.000 description 2
• 230000003204 osmotic effect Effects 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• 229940111202 pepsin Drugs 0.000 description 2
• 230000008855 peristalsis Effects 0.000 description 2
• 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 2
• 239000003208 petroleum Substances 0.000 description 2
• 229940124531 pharmaceutical excipient Drugs 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 108010079892 phosphoglycerol kinase Proteins 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 230000003169 placental effect Effects 0.000 description 2
• 108700004029 pol Genes Proteins 0.000 description 2
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
• 238000003752 polymerase chain reaction Methods 0.000 description 2
• 210000002729 polyribosome Anatomy 0.000 description 2
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
• 239000004810 polytetrafluoroethylene Substances 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
• 101150066583 rep gene Proteins 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000002864 sequence alignment Methods 0.000 description 2
• 239000008159 sesame oil Substances 0.000 description 2
• 235000011803 sesame oil Nutrition 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 239000003549 soybean oil Substances 0.000 description 2
• 235000012424 soybean oil Nutrition 0.000 description 2
• 239000008223 sterile water Substances 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 230000009897 systematic effect Effects 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
• GWNVDXQDILPJIG-CCHJCNDSSA-N 11-trans-Leukotriene C4 Chemical compound CCCCC\C=C/C\C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(O)=O)SC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O GWNVDXQDILPJIG-CCHJCNDSSA-N 0.000 description 1
• CZIHNRWJTSTCEX-UHFFFAOYSA-N 2 Acetylaminofluorene Chemical compound C1=CC=C2C3=CC=C(NC(=O)C)C=C3CC2=C1 CZIHNRWJTSTCEX-UHFFFAOYSA-N 0.000 description 1
• YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
• SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 102000041092 ABC transporter family Human genes 0.000 description 1
• 108091060858 ABC transporter family Proteins 0.000 description 1
• 101150092476 ABCA1 gene Proteins 0.000 description 1
• 101150110927 ABCC11 gene Proteins 0.000 description 1
• 101150083548 ABCC2 gene Proteins 0.000 description 1
• 101150036119 ABCC5 gene Proteins 0.000 description 1
• 101150095012 ABCC6 gene Proteins 0.000 description 1
• 101150038141 ABCC7 gene Proteins 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 101150037123 APOE gene Proteins 0.000 description 1
• 108700005241 ATP Binding Cassette Transporter 1 Proteins 0.000 description 1
• 102100020969 ATP-binding cassette sub-family E member 1 Human genes 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 229940123373 Adenovirus E1A gene Drugs 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 108091006515 Anion channels Proteins 0.000 description 1
• 102000037829 Anion channels Human genes 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 108010087504 Beta-Globulins Proteins 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 101150029409 CFTR gene Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 102100038909 Caveolin-2 Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 208000005595 Chronic Idiopathic Jaundice Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 208000000454 Congenital Hyperinsulinism Diseases 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 238000000018 DNA microarray Methods 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 101100216294 Danio rerio apoeb gene Proteins 0.000 description 1
• SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 102100036912 Desmin Human genes 0.000 description 1
• 108010044052 Desmin Proteins 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 108090000204 Dipeptidase 1 Proteins 0.000 description 1
• 101100290057 Drosophila virilis Mal-B1 gene Proteins 0.000 description 1
• 201000004943 Dubin-Johnson syndrome Diseases 0.000 description 1
• 208000012661 Dyskinesia Diseases 0.000 description 1
• 208000014094 Dystonic disease Diseases 0.000 description 1
• 101150029662 E1 gene Proteins 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 241000701867 Enterobacteria phage T7 Species 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000030914 Fatty Acid-Binding Human genes 0.000 description 1
• 102000016359 Fibronectins Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 101100238525 Homo sapiens ABCC11 gene Proteins 0.000 description 1
• 101000783786 Homo sapiens ATP-binding cassette sub-family E member 1 Proteins 0.000 description 1
• 101000740981 Homo sapiens Caveolin-2 Proteins 0.000 description 1
• 101001074035 Homo sapiens Zinc finger protein GLI2 Proteins 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 206010021024 Hypolipidaemia Diseases 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108700002232 Immediate-Early Genes Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 208000015592 Involuntary movements Diseases 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• ZQISRDCJNBUVMM-UHFFFAOYSA-N L-Histidinol Natural products OCC(N)CC1=CN=CN1 ZQISRDCJNBUVMM-UHFFFAOYSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• ZQISRDCJNBUVMM-YFKPBYRVSA-N L-histidinol Chemical compound OC[C@@H](N)CC1=CNC=N1 ZQISRDCJNBUVMM-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 108090000301 Membrane transport proteins Proteins 0.000 description 1
• 102000003939 Membrane transport proteins Human genes 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 241000713862 Moloney murine sarcoma virus Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 101710107068 Myelin basic protein Proteins 0.000 description 1
• 108010067385 Myosin Light Chains Proteins 0.000 description 1
• 102000016349 Myosin Light Chains Human genes 0.000 description 1
• 102000008763 Neurofilament Proteins Human genes 0.000 description 1
• 108010088373 Neurofilament Proteins Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 101710149086 Nuclease S1 Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 208000033390 Paroxysmal kinesigenic dyskinesia Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 101900232935 Pyrococcus furiosus DNA polymerase Proteins 0.000 description 1
• ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 108091034057 RNA (poly(A)) Proteins 0.000 description 1
• 108020005067 RNA Splice Sites Proteins 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 238000010240 RT-PCR analysis Methods 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 108020005091 Replication Origin Proteins 0.000 description 1
• 101100121445 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCN20 gene Proteins 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 241000713896 Spleen necrosis virus Species 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 101100460161 Streptomyces fradiae neoD gene Proteins 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 241000589500 Thermus aquaticus Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 102000013127 Vimentin Human genes 0.000 description 1
• 108010065472 Vimentin Proteins 0.000 description 1
• 102100035558 Zinc finger protein GLI2 Human genes 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• SUPKOOSCJHTBAH-UHFFFAOYSA-N adefovir Chemical compound NC1=NC=NC2=C1N=CN2CCOCP(O)(O)=O SUPKOOSCJHTBAH-UHFFFAOYSA-N 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 238000007818 agglutination assay Methods 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 125000003368 amide group Chemical group 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003302 anti-idiotype Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 229940125681 anticonvulsant agent Drugs 0.000 description 1
• 239000001961 anticonvulsive agent Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 238000003491 array Methods 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 102000006635 beta-lactamase Human genes 0.000 description 1
• 230000000035 biogenic effect Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
• 210000002798 bone marrow cell Anatomy 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 229950004398 broxuridine Drugs 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 229920006317 cationic polymer Polymers 0.000 description 1
• 230000004956 cell adhesive effect Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 208000012601 choreatic disease Diseases 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 229940126513 cyclase activator Drugs 0.000 description 1
• 229940095074 cyclic amp Drugs 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
• 229960003964 deoxycholic acid Drugs 0.000 description 1
• KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 210000005045 desmin Anatomy 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 239000005546 dideoxynucleotide Substances 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• 229960005156 digoxin Drugs 0.000 description 1
• MOAVUYWYFFCBNM-PUGKRICDSA-N digoxin(1-) Chemical compound C[C@H]([C@H]([C@H](C1)O)O)O[C@H]1O[C@H]([C@@H](C)O[C@H](C1)O[C@H]([C@@H](C)O[C@H](C2)O[C@@H](CC3)C[C@@H](CC4)[C@@]3(C)[C@@H](C[C@H]([C@]3(C)[C@H](CC5)C([CH-]O6)=CC6=O)O)[C@@H]4[C@]35O)[C@H]2O)[C@H]1O MOAVUYWYFFCBNM-PUGKRICDSA-N 0.000 description 1
• LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
• 238000003113 dilution method Methods 0.000 description 1
• 208000010118 dystonia Diseases 0.000 description 1
• 230000002900 effect on cell Effects 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 208000033961 familial 2 hyperinsulinemic hypoglycemia Diseases 0.000 description 1
• 108091022862 fatty acid binding Proteins 0.000 description 1
• 239000003337 fertilizer Substances 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 101150098622 gag gene Proteins 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 230000007614 genetic variation Effects 0.000 description 1
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
• 102000005396 glutamine synthetase Human genes 0.000 description 1
• 108020002326 glutamine synthetase Proteins 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 230000035931 haemagglutination Effects 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 239000012456 homogeneous solution Substances 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 102000044501 human ABCC4 Human genes 0.000 description 1
• 102000049088 human ABCC5 Human genes 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 238000002169 hydrotherapy Methods 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 208000029498 hypoalphalipoproteinemia Diseases 0.000 description 1
• 210000003016 hypothalamus Anatomy 0.000 description 1
• 125000001841 imino group Chemical group [H]N=* 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 230000008073 immune recognition Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 238000000760 immunoelectrophoresis Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000003017 in situ immunoassay Methods 0.000 description 1
• 238000012625 in-situ measurement Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 210000003000 inclusion body Anatomy 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 210000003963 intermediate filament Anatomy 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 210000004020 intracellular membrane Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 238000011813 knockout mouse model Methods 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 229910052748 manganese Inorganic materials 0.000 description 1
• 239000011572 manganese Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000009061 membrane transport Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 238000005065 mining Methods 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 108010066416 multidrug resistance-associated protein 3 Proteins 0.000 description 1
• 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
• 239000003471 mutagenic agent Substances 0.000 description 1
• 231100000707 mutagenic chemical Toxicity 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 230000002107 myocardial effect Effects 0.000 description 1
• 108010065781 myosin light chain 2 Proteins 0.000 description 1
• 239000005445 natural material Substances 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000005044 neurofilament Anatomy 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 150000002891 organic anions Chemical class 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 230000010399 physical interaction Effects 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 210000005059 placental tissue Anatomy 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920000447 polyanionic polymer Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 238000009117 preventive therapy Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000009465 prokaryotic expression Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 239000002994 raw material Substances 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 210000005227 renal system Anatomy 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 108090000064 retinoic acid receptors Proteins 0.000 description 1
• 102000003702 retinoic acid receptors Human genes 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000002342 ribonucleoside Substances 0.000 description 1
• 210000003752 saphenous vein Anatomy 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 210000004989 spleen cell Anatomy 0.000 description 1
• 210000004988 splenocyte Anatomy 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000003270 steroid hormone Substances 0.000 description 1
• 108020003113 steroid hormone receptors Proteins 0.000 description 1
• 102000005969 steroid hormone receptors Human genes 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000005556 structure-activity relationship Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
• 229960000278 theophylline Drugs 0.000 description 1
• 238000009210 therapy by ultrasound Methods 0.000 description 1
• 150000007970 thio esters Chemical class 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 239000003104 tissue culture media Substances 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 229960001722 verapamil Drugs 0.000 description 1
• 108090000195 villin Proteins 0.000 description 1
• 210000005048 vimentin Anatomy 0.000 description 1
• 230000006648 viral gene expression Effects 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1